🇺🇸 FDA
Patent

US 8440309

Crosslinked polymers with the crosslinker as therapeutic for sustained release

granted A61KA61K47/30A61K47/60

Quick answer

US patent 8440309 (Crosslinked polymers with the crosslinker as therapeutic for sustained release) held by Covidien LP expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Covidien LP
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/30, A61K47/60, A61K47/6903